Recent Advances in Structure, Function, and Pharmacology of Class A Lipid GPCRs: Opportunities and Challenges for Drug Discovery
Great progress has been made over the past decade in understanding the structural, functional, and pharmacological diversity of lipid GPCRs. From the first determination of the crystal structure of bovine rhodopsin in 2000, much progress has been made in the field of GPCR structural biology. The ext...
Main Authors: | R. N. V. Krishna Deepak, Ravi Kumar Verma, Yossa Dwi Hartono, Wen Shan Yew, Hao Fan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/15/1/12 |
Similar Items
-
Predicting allosteric effects from orthosteric binding in Hsp90-ligand interactions : implications for fragment-based drug design
by: Chandramohan, Arun, et al.
Published: (2018) -
What Makes GPCRs from Different Families Bind to the Same Ligand?
by: Kwabena Owusu Dankwah, et al.
Published: (2022-06-01) -
Non-Peptide Agonists and Antagonists of the Prokineticin Receptors
by: Roberta Lattanzi, et al.
Published: (2022-12-01) -
Ligands and Beyond: Mechanosensitive Adhesion GPCRs
by: Hsi-Hsien Lin, et al.
Published: (2022-02-01) -
A Potential Blueprint for the Design of Biased Ligands for Aminergic GPCRs
by: Marcel Bermudez
Published: (2022-11-01)